Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial

被引:0
作者
Anh Dam Tran
Angela M. Hong
Mai T. H. Nguyen
Gerald Fogarty
Victoria Steel
Elizabeth Paton
Rachael L. Morton
机构
[1] UNSW,National Drug and Alcohol Research Centre
[2] The University of Sydney,NHMRC Clinical Trials Centre, Faculty of Medicine and Health
[3] The University of Sydney,Melanoma Institute of Australia
[4] The University of Sydney,Sydney Medical School
[5] St Vincent’s Clinic,Genesis Cancer Care
[6] Monash University,Melanoma and Skin Cancer Trials
来源
PharmacoEconomics - Open | 2022年 / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:587 / 594
页数:7
相关论文
共 52 条
[1]  
Bafaloukos D(2004)The treatment of brain metastases in melanoma patients Cancer Treat Rev 30 515-520
[2]  
Gogas H(2013)Predictors and survival in patients with melanoma brain metastases Med Oncol 30 466-542
[3]  
Bottoni U(2016)Management of brain metastases in patients with melanoma J Oncol Pract 12 536-409
[4]  
Clerico R(2016)Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial JAMA 316 401-3141
[5]  
Paolino G(2011)Whole brain radiotherapy after local treatment of brain metastases in melanoma patients—a randomised phase III trial BMC Cancer 11 142-212297
[6]  
Chukwueke U(2019)Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: statistical analysis plan Trials 20 477-1172
[7]  
Batchelor T(2019)Adjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase III trial J Clin Oncol 37 3132-816
[8]  
Brastianos P(2016)Evaluating cost benefits of combination therapies for advanced melanoma Drugs Context 5 212297-1064
[9]  
Brown PD(2018)The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England Eur J Health Econ 19 1163-547
[10]  
Jaeckle K(2017)Estimated healthcare costs of melanoma in Australia over 3 years post-diagnosis Appl Health Econ Health Policy 15 805-432